Home › NDC Lookup › RxCUI directory › RxCUI 309308

Ciprofloxacin 50 MG/ML Oral Suspension — RxCUI 309308

RxNorm drug concept · Semantic clinical drug
RxCUI 309308 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI309308
Official nameCiprofloxacin 50 MG/ML Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asciprofloxacin 250 MG per 5 ML Oral Suspension; ciprofloxacin 250 MG in 5 mL Oral Suspension
FDA products mapped6
Package NDCs mapped6
Reported Medicaid activity (SDUD)6,720 prescriptions · 29 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ciprofloxacin Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • These drops are an antibiotic specifically for bacterial eye infections. They're approved to treat two conditions: bacterial conjunctivitis — which most people call pink eye — and...
  • What exactly does ciprofloxacin eye drops treat?
  • Yes, especially for corneal ulcers — the schedule is intentionally intensive at the start to get the infection under control quickly. You'll be using drops very frequently the firs...
  • The dosing schedule looks really complicated — do I really need to use them that often?
📖 Read our full Ciprofloxacin Ophthalmic guide →

🕸️ Concept Web — How Ciprofloxacin 50 MG/ML Oral Suspension Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ciprofloxacin 50 MG/ML Oral Suspension RxCUI 309308

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Ciprofloxacin 2551
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Cipro 203563
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ciprofloxacin Oral Suspension 371524
    • Ciprofloxacin Oral Liquid Product 1152117
    • Ciprofloxacin Oral Product 1152118
    • Ciprofloxacin Oral Suspension [Cipro] 365849
    • Cipro Oral Liquid Product 1170898
    • Cipro Oral Product 1170899
    • Oral Suspension 316969
    • Oral Liquid Product 1151137
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ciprofloxacin 50 MG/ML SCDC · 329442
  • Ciprofloxacin Oral Suspension SCDF · 371524
  • Ciprofloxacin Oral Liquid Product SCDG · 1152117
  • Ciprofloxacin Oral Product SCDG · 1152118

Brand-Name Concepts

  • Ciprofloxacin 50 MG/ML Oral Suspension [Cipro] SBD · 213224
  • Ciprofloxacin 50 MG/ML [Cipro] SBDC · 573142
  • Ciprofloxacin Oral Suspension [Cipro] SBDF · 365849
  • Cipro Oral Liquid Product SBDG · 1170898
  • Cipro Oral Product SBDG · 1170899
  • Cipro BN · 203563

📦 FDA Products & Package NDCs

6 products · 6 package NDCs
6 package NDCs map to RxCUI 309308 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50419-0754-01 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-754-01) Cipro Bayer HealthCare Pharmaceuticals Inc. 1987-10-22
50419-0758-01 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-758-01) Cipro Bayer HealthCare Pharmaceuticals Inc. 1987-10-22
50419-0773-01 1 KIT in 1 KIT (50419-773-01) * 100 mL in 1 BOTTLE, GLASS... Cipro Bayer HealthCare Pharmaceuticals Inc. 1997-09-26
50419-0777-01 1 KIT in 1 KIT (50419-777-01) * 100 mL in 1 BOTTLE, GLASS... Cipro Bayer HealthCare Pharmaceuticals Inc. 1997-09-26
62135-0392-42 1 KIT in 1 KIT (62135-392-42) * 100 mL in 1 BOTTLE * 100... ciprofloxacin Chartwell RX, LLC 2023-01-27
62135-0393-42 1 KIT in 1 KIT (62135-393-42) * 100 mL in 1 BOTTLE * 100... ciprofloxacin Chartwell RX, LLC 2023-03-20
Observed labelers: Bayer HealthCare Pharmaceuticals Inc. (4) · Chartwell RX, LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.